Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
Barth-Jaeggi T, Steinmann P, Mieras L, van Brakel W, Richardus JH, Tiwari A, Bratschi M, Cavaliero A, Vander Plaetse B, Mirza F, Aerts A; LPEP study group. Barth-Jaeggi T, et al. Among authors: cavaliero a. BMJ Open. 2016 Nov 17;6(11):e013633. doi: 10.1136/bmjopen-2016-013633. BMJ Open. 2016. PMID: 27856484 Free PMC article.
Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
Mieras L, Anthony R, van Brakel W, Bratschi MW, van den Broek J, Cambau E, Cavaliero A, Kasang C, Perera G, Reichman L, Richardus JH, Saunderson P, Steinmann P, Yew WW. Mieras L, et al. Among authors: cavaliero a. Infect Dis Poverty. 2016 Jun 8;5(1):46. doi: 10.1186/s40249-016-0140-y. Infect Dis Poverty. 2016. PMID: 27268059 Free PMC article. Review.
Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
Richardus JH, Tiwari A, Barth-Jaeggi T, Arif MA, Banstola NL, Baskota R, Blaney D, Blok DJ, Bonenberger M, Budiawan T, Cavaliero A, Gani Z, Greter H, Ignotti E, Kamara DV, Kasang C, Manglani PR, Mieras L, Njako BF, Pakasi T, Pandey BD, Saunderson P, Singh R, Smith WCS, Stäheli R, Suriyarachchi ND, Tin Maung A, Shwe T, van Berkel J, van Brakel WH, Vander Plaetse B, Virmond M, Wijesinghe MSD, Aerts A, Steinmann P. Richardus JH, et al. Among authors: cavaliero a. Lancet Glob Health. 2021 Jan;9(1):e81-e90. doi: 10.1016/S2214-109X(20)30396-X. Epub 2020 Oct 29. Lancet Glob Health. 2021. PMID: 33129378 Free article. Review.
Leprosy post-exposure prophylaxis risks not adequately assessed - Author's reply.
Richardus JH, Mieras L, Saunderson P, Ignotti E, Virmond M, Arif MA, Pandey BD, Cavaliero A, Steinmann P. Richardus JH, et al. Among authors: cavaliero a. Lancet Glob Health. 2021 Apr;9(4):e402-e403. doi: 10.1016/S2214-109X(21)00047-4. Lancet Glob Health. 2021. PMID: 33740406 Free article. No abstract available.
The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study.
Blok DJ, Steinmann P, Tiwari A, Barth-Jaeggi T, Arif MA, Banstola NL, Baskota R, Blaney D, Bonenberger M, Budiawan T, Cavaliero A, Gani Z, Greter H, Ignotti E, Kamara DV, Kasang C, Manglani PR, Mieras L, Njako BF, Pakasi T, Saha UR, Saunderson P, Smith WCS, Stäheli R, Suriyarachchi ND, Tin Maung A, Shwe T, van Berkel J, van Brakel WH, Vander Plaetse B, Virmond M, Wijesinghe MSD, Aerts A, Richardus JH. Blok DJ, et al. Among authors: cavaliero a. PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009279. doi: 10.1371/journal.pntd.0009279. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33788863 Free PMC article.
12 results